5,028
Views
2
CrossRef citations to date
0
Altmetric
Report

Development of a robust and semi-automated two-step antibody purification process

, , , , , , & ORCID Icon show all
Article: 2000348 | Received 27 Jul 2021, Accepted 27 Oct 2021, Published online: 15 Nov 2021

References

  • Schmidt PM, Abdo M, Butcher RE, Yap M-Y, Scotney PD, Ramunno ML, Martin-Roussety G, Owczarek C, Hardy MP, Chen C-G, et al. A robust robotic high-throughput antibody purification platform. J Chromatog A. 2016;1455:9–10. doi:10.1016/j.chroma.2016.05.076.
  • Evans ST, Stewart KD, Afdahl C, Patel R, Newell KJ. Optimization of a micro-scale, high throughput process development tool and the demonstration of comparable process performance and product quality with biopharmaceutical manufacturing processes. J Chromatog A. 2017;1506:73–81. doi:10.1016/j.chroma.2017.05.041. PMID: 28551021.
  • Luan P, Lee S, Arena TA, Paluch M, Kansopon J, Viajar S, Begum Z, Chiang N, Nakamura G, Hass PE, et al. Automated high throughput microscale antibody purification workflows for accelerating antibody discovery. mAbs. 2018;10(4):624–35. doi:10.1080/19420862.2018.1445450.
  • Barnard GC, Hougland MD, Rajendra Y. High throughput mAb expression and purification platform based on transient CHO. Biotechnol Prog. 2015;31(1):239–47. doi:10.1002/btpr.2012.
  • Smith ER, Begley DW, Anderson V, Raymond AC, Haffner TE, Robinson JI, Edwards TE, Duncan N, Gerdts CJ, Mixon MB, et al. The protein maker: an automated system for high‐throughput parallel purification. Acta Cryst. 2011;67(9):1015–21. doi:10.1107/s1744309111028776.
  • Helie G, Parat M, Masse F, Gerdts CJ, Loisel TP, Matte A. Application of the protein maker as a platform purification system for therapeutic antibody research and development. Comput Struct Biotechnol J. 2016;14:238–44. doi:10.1016/j.csbj.2016.06.001. PMID: 27418955.
  • Yoo D, Provchy J, Park C, Schulz C, Walker K. Automated high-throughput protein purification using an AKTApurifier and a CETAC autosampler. J Chromatog A. 2014;1344:23–30. doi:10.1016/j.chroma.2014.04.014. PMID: 24768125.
  • Zhang C, Long AM, Swalm B, Charest K, Wang Y, Hu J, Schulz C, Goetzinger W, Hall BE. Development of an automated mid-scale parallel protein purification system for antibody purification and affinity chromatography. Protein Expr Purif. 2016;128:29–35. doi:10.1016/j.pep.2016.08.005. PMID: 27498022.
  • Schmitz S, Schonfeld DL, Freitag B, Gotzberger-Schad C, Fischer M, Linden L. Keeping pace with the increasing demand for high quality drug candidates in pharmaceutical research: development of a new two-step preparative tandem high performance chromatographic system for the purification of antibodies. J Chromatog B. 2019;1104:18–28. doi:10.1016/j.chromb.2018.11.005.
  • Becker W, Scherer A, Faust C, Bauer DK, Scholtes S, Rao E, Hofmann J, Schauder R, Langer T. A fully automated three-step protein purification procedure for up to five samples using the NGC chromatography system. Protein Expr Purif. 2019;153:1–6. doi:10.1016/j.pep.2018.08.003.
  • GE Healthcare Life Sciences. MabSelect PrismA affinity chromatography. Instruction 29262586 AD. 2019;1–32.
  • GE Healthcare Life Sciences. Lifetime performance study of MabSelect PrismA during repeated clean-in-place cycles. Application Note KA1061080618AN. 2018;1–4
  • Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. Downstream processing of monoclonal antibodies - Application of platform approaches. J Chromatog B. 2007;848:28–39. doi:10.1016/j.jchromb.2006.09.026.
  • Schwarz H, Schmittner M, Duschl A, Horejs-Hoeck J, Li L. Residual endotoxin contaminations in recombinant proteins are sufficient to activate human CD1c+ dendritic cells. PLOS One. 2014;9(12):e113840. doi:10.1371/journal.pone.0113840. PMID: 25478795.
  • Malyala P, Singh M. Endotoxin limits in formulations for preclinical research. J Pharm Sci. 2008;97(6):2041–44. doi:10.1002/jps.21152. PMID: 17847072.